AGP Executive Report
Last update: 3 hours agoPharma & Access: Santhera Pharmaceuticals says revenue jumped 101% to CHF 48.3m in H1 2026, driven by strong AGAMREE® sales and a big Nxera licensing upfront payment, with expanded patient access across Europe and APAC. Cancer Care (Uzbek patient): Doctors used a “green corridor” to send an 11-year-old Uzbek girl’s cancer-affected femur to radiation treatment abroad, then planned limb-preserving reimplantation. Public Health & Safety (Uzbek link): A report on melanoma biomarker research includes Uzbek co-authors, arguing such tests must be validated across many hospitals before clinical use. Health & Environment (Uzbekistan): Uzcosmos is rolling out satellite-based “virtual gauge” monitoring to improve water management—key for agriculture and health outcomes in a water-stressed country. Human Rights & Health Risk: Human Rights Watch urges Uzbekistan to protect imprisoned Karakalpak lawyer/blogger Dauletmurat Tazhimuratov from further beatings and torture. Health Policy Context: Uzbekistan’s death-penalty debate is reignited after a reported child abuse case, with senior officials weighing in.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
